Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Cellular and Molecular Life Sciences : CMLS|January 30, 2023
EGFL7 loss correlates with increased VEGF-D expression, upregulating hippocampal adult neurogenesis and improving spatial learning and memoryKathrin Barth, Verica Vasić, Brennan McDonald, et al.
Oncoimmunology|July 9, 2015
Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosisMarieta Toma, Rebekka Wehner, Anja Kloß, et al.
Oncotarget|October 31, 2015
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastasesPatrick N Harter, Simon Bernatz, Alexander Scholz, et al.
Cancers|January 1, 2020
Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor OriginJulia Biedermann, Matthias Preussler, Marina Conde, et al.
The Journal of Investigative Dermatology|January 30, 2023
Identification of Epigenetically Regulated Genes Distinguishing Intracranial from Extracranial Melanoma MetastasesDana Westphal, Matthias Meinhardt, Konrad Grützmann, et al.
Genome Medicine|September 15, 2022
A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapyFlorian A Büttner, Stefan Winter, Viktoria Stühler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2016
PI3K Pathway Inhibition Achieves Potent Antitumor Activity in Melanoma Brain Metastases In Vitro and In VivoHeike Niessner, Jennifer Schmitz, Ghazaleh Tabatabai, et al.
Cancer Immunology Research|October 11, 2019
Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGFMariangela Di Tacchio, Jadranka Macas, Jakob Weissenberger, et al.
Oncotarget|January 10, 2018
Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomasTareq A Juratli, Christian Thiede, Mara V A Koerner, et al.
EMBO Molecular Medicine|December 16, 2015
Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastomaAlexander Scholz, Patrick N Harter, Sebastian Cremer, et al.
Pageof 6